Endometrial Cancer Market 2019 Size, Historical Analysis, Emerging Trends, Future Scope Growth Rate, Latest Technologies and Business Opportunity 1
Global Endometrial Cancer Market Research Report, by Diagnosis (Pelvic Examination, Transvaginal Ultrasound, Endometrial Biopsy), Treatment (Hysterectomy, Radiation), End-User (Hospitals & Clinics, Ambulatory Surgical Centers) – Global Forecast Till 2023

Global Endometrial Cancer Market Highlight

Endometrial cancer is termed as the abnormal growth of endometrium cells in the uterus, also known as uterine cancer. Endometrial cancer is often diagnosed at an early stage due to the most common symptom being abnormal vaginal bleeding.
The global endometrial cancer market is estimated to witness remarkable growth due to the increasing prevalence of endometrial cancer. Other influential factors such as the growing obesity among women, rise in menopausal hormone therapy, change in an inactive lifestyle, socioeconomic factors, increasing consumption of an unhealthy diet, increasing prevalence of Polycystic Ovarian Syndrome (PCOS), and growing occurrence of breast or ovarian tumor are contributing towards the market growth.  Additionally, diabetes is another risk factor that leads to endometrial cancer. However, factors such as high expenditure of diagnostic measures, expensive treatments, and side effects related to hysterectomy measures are estimated to hamper the market growth during the forecast period.

GET FREE SAMPLE REPORT@https://www.marketresearchfuture.com/sample_request/6226

Endometrial Cancer Market- Segmental Analysis

The global endometrial cancer market is segmented based on diagnosis, treatment, end-user, and region. 
Based on the diagnosis, the endometrial cancer market is segmented into endometrial biopsy, ultrasound, dilation and curettage (D&C), pelvic examination, transvaginal and laparoscopy. 
Based on treatment, the market has been segmented into radiation, chemotherapy, hysterectomy techniques, hormone therapy, and palliative care. The radiation category is segmented into external radiation and internal radiation (brachytherapy). The chemotherapy segment is segmented into paclitaxel, doxorubicin, carboplatin, and cisplatin. The hysterectomy techniques segment is sub-segmented into total vaginal hysterectomy, total laparoscopic hysterectomy, open abdominal hysterectomy, and robotic hysterectomy. Hormonal therapy is sub-segmented into luteinizing hormone-releasing hormone agonists, tamoxifen, progestins, and aromatase inhibitors. 
Based on end-user, the global endometrial cancer market is segmented into hospitals and clinics, diagnostic centers, gynecology centers, ambulatory surgical centers, feminist health centers, and others.  
Based on the region, the global endometrial cancer market is segmented into the North & Latin America, Europe, Asia-Pacific, and the Middle East and Africa.

Endometrial Cancer Market- Regional Analysis

North America dominates the endometrial cancer market share, owing to the increasing prevalence of breast cancer, rising healthcare expenditure and growing obesity within the female population and is estimated to retain its foremost market share over the forecast period due to these influential factors.

Europe is estimated as the second largest regional market in the global endometrial cancer market due to the rising prevalence of ovarian cancer in this region and is estimated to sustain its market growth over the forecast period.

Asia-Pacific was anticipated to be the fastest growing region for the global endometrial cancer market. The market is expected to witness growth owing to the rising prevalence of diabetes in women, changing lifestyle, and growing obesity within the female population. Additonally, growing number of government initiatives to improve the healthcare sector in emerging economies such s india, and china, among others, is also a sginifcant driing factor for the region and is estimated to contribute to the market growth of the global endometrial cancer market over the forecast period.

The Middle East & Africa region is estimated to show gradual growth in the global endometrial cancer market due to the presence of strict government policies and regulations, and low-income economies. On the other hand, the market is predicted to witness growth owing to the rising healthcare expenditure by the governments, growing private sector in the healthcare sector, and rise in insurance coverage in the Middle East.

Endometrial Cancer Market Key players

The key market players in the global endometrial cancer market are General Electric Company, Pfizer Inc., Koninklijke Philips N.V., LUPIN, Bayer AG, PHYTON, Celgene Corporation, Conceptus Inc., Hologic Inc., Johnson & Johnson, Karl Storz GmbH & Co. Kg, CooperSurgical Inc., LiNA Medical USA, and Boston Scientific Corporation.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226

Leave a Reply

Your email address will not be published. Required fields are marked *